10,000+ stock pitches from top investors available on joinyellowbrick.com
Redmile Group, LLC 13F Holdings
Holdings from the most recent 13F from Redmile Group, LLC
Filed: 2024-08-14 (Q2 2024) | Holdings: 63 | Value: $1.7B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
---|---|---|---|---|---|---|---|
Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
KRYS - KRYSTAL BIOTECH INC | Reduce 32% $(89.5M) | 11.34% | $187.5M | -31.24% | -11.11% | ||
FOLD - AMICUS THERAPEUTICS INC | Reduce 20% $(26.4M) | 6.35% | $105.1M | -51.19% | -17.55% | ||
NRIX - NURIX THERAPEUTICS INC | Reduce 1% $(1.2M) | 5.58% | $92.3M | -48.19% | +2.18% | ||
STOK - STOKE THERAPEUTICS INC | Reduce 7% $(4.8M) | 3.86% | $63.8M | -19.93% | -16.75% | ||
IMNM - IMMUNOME INC | 3.58% | $59.2M | -35.78% | -27.96% | |||
RGNX - REGENXBIO INC | 3.23% | $53.5M | -29.29% | -20.54% | |||
LIVN - LIVANOVA PLC | Reduce 10% $(5.9M) | 3.08% | $51.0M | -2.80% | +12.12% | ||
REPL - REPLIMUNE GROUP INC | Add 49% ($16.5M) | 3.03% | $50.1M | -5.10% | +8.00% | ||
ADCT - ADC THERAPEUTICS SA | 2.92% | $48.3M | +3.41% | -18.43% | |||
KYMR - KYMERA THERAPEUTICS INC | Reduce 9% $(4.6M) | 2.85% | $47.1M | +5.67% | -4.53% | ||
SRRK - SCHOLAR ROCK HLDG CORP | Reduce 15% $(8.1M) | 2.75% | $45.4M | +283.93% | +180.02% | ||
ZYME - ZYMEWORKS INC | Reduce 6% $(3.0M) | 2.68% | $44.3M | +22.38% | +49.13% | ||
FATE - FATE THERAPEUTICS INC | 2.61% | $43.2M | -64.72% | -41.11% | |||
COGT - COGENT BIOSCIENCES INC | Add 21% ($7.1M) | 2.45% | $40.5M | -16.69% | +2.42% | ||
BEAM - BEAM THERAPEUTICS INC | Reduce 9% $(4.1M) | 2.41% | $39.9M | -29.03% | +0.46% | ||
SLN - SILENCE THERAPEUTICS PLC | Reduce 1% $(254.1K) | 2.31% | $38.3M | -65.19% | -21.89% | ||
AKRO - AKERO THERAPEUTICS INC | Reduce 13% $(5.7M) | 2.29% | $37.9M | +124.17% | +14.70% | ||
BHVN - BIOHAVEN LTD | Reduce 7% $(2.6M) | 2.28% | $37.7M | -62.76% | +14.88% | ||
NGNE - NEUROGENE INC | Add 8% ($2.9M) | 2.23% | $36.9M | -46.71% | +0.51% | ||
PLRX - PLIANT THERAPEUTICS INC | Add 4% ($1.2M) | 2.09% | $34.5M | -89.34% | +1.14% | ||
CTLT - CATALENT INC | Reduce 6% $(2.1M) | 2.02% | $33.5M | -0.67% | |||
ANNX - ANNEXON INC | Add 17% ($4.5M) | 1.90% | $31.5M | -59.52% | +5.88% | ||
BSX - BOSTON SCIENTIFIC CORP | Reduce 30% $(13.1M) | 1.82% | $30.1M | +32.08% | +13.34% | ||
IDYA - IDEAYA BIOSCIENCES INC | Reduce 18% $(5.7M) | 1.61% | $26.7M | -42.41% | -29.82% | ||
CLDX - CELLDEX THERAPEUTICS INC NEW | Reduce 20% $(6.6M) | 1.61% | $26.6M | -37.87% | -29.72% | ||
ABSI - ABSCI CORPORATION | 1.54% | $25.4M | -26.47% | -24.06% | |||
KROS - KEROS THERAPEUTICS INC | 1.53% | $25.2M | -69.62% | +26.95% | |||
ALXO - ALX ONCOLOGY HLDGS INC | Reduce 7% $(1.7M) | 1.47% | $24.3M | -81.14% | -50.00% | ||
FDMT - 4D MOLECULAR THERAPEUTICS IN | Reduce 15% $(3.9M) | 1.36% | $22.5M | -72.73% | -41.13% | ||
STTK - SHATTUCK LABS INC | 1.31% | $21.7M | -68.97% | -60.67% | |||
IGMS - IGM BIOSCIENCES INC | 1.28% | $21.1M | -87.58% | +0.53% | |||
IMVT - IMMUNOVANT INC | Reduce 26% $(6.6M) | 1.15% | $19.0M | -48.31% | -13.20% | ||
ISRG - INTUITIVE SURGICAL INC | New Purchase | 1.07% | $17.7M | +6.84% | +10.64% | ||
AUGX - AUGMEDIX INC | 0.87% | $14.4M | |||||
ETNB - 89BIO INC | Reduce 23% $(4.2M) | 0.85% | $14.0M | +27.39% | +1.02% | ||
ARDX - ARDELYX INC | Reduce 14% $(2.3M) | 0.84% | $13.9M | -37.22% | -13.57% | ||
SYK - STRYKER CORPORATION | Reduce 9% $(1.3M) | 0.81% | $13.4M | +12.43% | +16.95% | ||
PRME - PRIME MEDICINE INC | 0.64% | $10.7M | -57.35% | -20.73% | |||
BPMC - BLUEPRINT MEDICINES CORP | New Purchase | 0.62% | $10.2M | +34.02% | -7.23% | ||
ESTA - ESTABLISHMENT LABS HLDGS INC | New Purchase | 0.59% | $9.7M | -11.54% | -12.10% | ||
NUVB - NUVATION BIO INC | New Purchase | 0.54% | $8.9M | -36.30% | -6.41% | ||
TRDA - ENTRADA THERAPEUTICS INC | Reduce 56% $(10.3M) | 0.48% | $8.0M | -56.74% | +9.85% | ||
ACIU - AC IMMUNE SA | New Purchase | 0.44% | $7.2M | -40.00% | -3.33% | ||
VERV - VERVE THERAPEUTICS INC | Reduce 9% $(688.6K) | 0.43% | $7.1M | +138.63% | +2.79% | ||
RPTX - REPARE THERAPEUTICS INC | New Purchase | 0.39% | $6.4M | -53.47% | +2.64% | ||
CYTK - CYTOKINETICS INC | New Purchase | 0.37% | $6.1M | -43.04% | -12.60% | ||
VTYX - VENTYX BIOSCIENCES INC | New Purchase | 0.30% | $5.0M | +22.16% | -3.61% | ||
BOLD - BOUNDLESS BIO INC | Reduce 7% $(307.5K) | 0.24% | $4.0M | -65.22% | +0.67% | ||
ATRA - ATARA BIOTHERAPEUTICS INC | New Purchase | 0.23% | $3.8M | +1.65% | +52.09% | ||
STXS - STEREOTAXIS INC | New Purchase | 0.23% | $3.8M | +15.90% | +4.62% | ||
ABT - ABBOTT LABS | Reduce 100% | 0.00% | $0.00 | ||||
ALGN - ALIGN TECHNOLOGY INC | Reduce 100% | 0.00% | $0.00 | ||||
ELV - ELEVANCE HEALTH INC | Reduce 100% | 0.00% | $0.00 | ||||
CI - THE CIGNA GROUP | Reduce 100% | 0.00% | $0.00 | ||||
DCPH - DECIPHERA PHARMACEUTICALS IN | Reduce 100% | 0.00% | $0.00 | ||||
EVH - EVOLENT HEALTH INC | Reduce 100% | 0.00% | $0.00 | ||||
GRTS - GRITSTONE BIO INC | Reduce 100% | 0.00% | $0.00 | ||||
HCA - HCA HEALTHCARE INC | Reduce 100% | 0.00% | $0.00 | ||||
PGNY - PROGYNY INC | Reduce 100% | 0.00% | $0.00 | ||||
ICLR - ICON PLC | Reduce 100% | 0.00% | $0.00 |